IRIS
ALTIERI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.253
NA - Nord America 1.066
SA - Sud America 520
EU - Europa 377
AF - Africa 155
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.003
SG - Singapore 965
VN - Vietnam 400
BR - Brasile 378
HK - Hong Kong 341
CN - Cina 201
BD - Bangladesh 149
ZA - Sudafrica 115
IT - Italia 108
NL - Olanda 101
FR - Francia 92
AR - Argentina 60
IN - India 41
MX - Messico 26
IQ - Iraq 23
CA - Canada 21
CO - Colombia 17
EC - Ecuador 17
JP - Giappone 14
TR - Turchia 14
DE - Germania 13
ID - Indonesia 13
MY - Malesia 13
MA - Marocco 12
GB - Regno Unito 11
RU - Federazione Russa 11
VE - Venezuela 11
PE - Perù 10
PK - Pakistan 10
PY - Paraguay 9
CL - Cile 8
SA - Arabia Saudita 8
EG - Egitto 7
PL - Polonia 7
TH - Thailandia 7
UA - Ucraina 7
AZ - Azerbaigian 6
ES - Italia 6
PH - Filippine 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
KE - Kenya 5
UY - Uruguay 5
RS - Serbia 4
TN - Tunisia 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
AL - Albania 2
AU - Australia 2
EE - Estonia 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BZ - Belize 1
CG - Congo 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 4.374
Salva come PNG Salva come JPEG
Città #
San Jose 411
Singapore 357
Hong Kong 330
Ashburn 145
Ho Chi Minh City 137
Johannesburg 107
Lauterbourg 87
Hanoi 79
Boardman 54
Dallas 46
Los Angeles 40
São Paulo 29
Beijing 28
New York 24
Council Bluffs 18
Buffalo 17
Rio de Janeiro 16
Columbus 15
Da Nang 15
Hefei 14
Haiphong 13
Milan 13
Parma 12
Biên Hòa 10
Des Moines 10
Mexico City 10
Tokyo 9
Brasília 8
Can Tho 8
Orem 8
Asunción 7
Baghdad 7
Belo Horizonte 7
Curitiba 7
Kuala Lumpur 7
Montreal 7
Santa Clara 7
Brooklyn 6
Casablanca 6
Chennai 6
Guayaquil 6
Lima 6
Rome 6
Salvador 6
San Francisco 6
Warsaw 6
Würzburg 6
Buenos Aires 5
Chicago 5
Denver 5
La Paz 5
Medellín 5
Phoenix 5
Quito 5
Tashkent 5
Thái Bình 5
Toronto 5
Wuhan 5
Zhengzhou 5
Baku 4
Bogotá 4
Cairo 4
Cape Town 4
Changsha 4
Erbil 4
Fortaleza 4
Frankfurt am Main 4
Istanbul 4
Joinville 4
Karachi 4
Montevideo 4
Nairobi 4
New Delhi 4
Piracicaba 4
Recife 4
Santiago 4
Shanghai 4
Shijiazhuang 4
São José 4
São José dos Campos 4
Tianjin 4
Verona 4
Bangkok 3
Basra 3
Belgrade 3
Bishkek 3
Bắc Giang 3
Campinas 3
Canoas 3
Catania 3
Charlotte 3
Conselheiro Lafaiete 3
Criciúma 3
Delhi 3
Dhaka 3
Elk Grove Village 3
Guarulhos 3
Jakarta 3
Jeddah 3
Lahore 3
Totale 2.385
Salva come PNG Salva come JPEG
Nome #
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 98
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter study 87
Machine learning-based survival prediction tool for adrenocortical carcinoma 84
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management 79
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 77
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma 70
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 68
4. Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 66
Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept 65
"Expression and prognostic relevance of PD-1, PD-L1 and CTLA-4 immune checkpoints in adrenocortical carcinoma" 64
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study 61
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 60
SOX2+ sustentacular cells are stem cells of the postnatal adrenal medulla 60
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies 59
An Italian Survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 59
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors 57
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 57
Single-nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoral adrenal gland 56
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma 55
Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report 55
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 54
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 54
Medical therapy of endogenous Cushing's syndrome with steroidogenesis inhibitors: treatment rationale, available drugs, and therapeutic effects 53
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 52
Adrenal disorders: Is there Any role for vitamin D? 51
The interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma 51
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 51
Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus 50
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: Impact on poor prognosis and impaired responsiveness to immunotherapy 50
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 50
Clinical and penile Doppler outcomes using a modified, tourniquet free, Nesbit plication for severe Peyronie's disease 50
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma 50
Chronotype and cardio metabolic health in obesity: does nutrition matter? 47
Circulating microRNA Expression in Cushing's Syndrome 47
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 46
Next-generation therapies for adrenocortical carcinoma 46
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 45
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 45
Focus on vitamin D and the adrenal gland 45
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 45
Vitamin D and chronic diseases: the current state of the art 44
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 43
Management of Patients with Glucocorticoid-Related Diseases and COVID-19 43
Adrenocortical tumors and insulin resistance. What is the first step? 43
Low bone mineral density in a growth hormone deficient (GHD) adolescent 43
The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors 43
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma 42
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 42
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution 42
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 41
Nutrition and neuroendocrine tumors: an update of the literature 41
Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function 41
Sex differences in carcinoid syndrome: A gap to be closed 41
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas 40
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 39
Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma 39
Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome 39
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study 38
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma 38
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study 37
Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature 37
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 37
Gemcitabine-Based Chemotherapy In Adrenocortical Carcinoma: A Multicentric Study On Efficacy and Predictive Factors 37
Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication 36
Shedding new light on female fertility: The role of vitamin D 36
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma 36
Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study 36
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness 36
Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of Diabetes Mellitus and Pancreatic Cancer 35
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma 35
Does vitamin D play a role in Autoimmune Endocrine Disorders? A proof of concept 35
Outcome of Immunotherapy in Adrenocortical Carcinoma - A retrospective cohort study 35
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 34
Editorial: Endocrine malignancies: from pathophysiology to current clinical and surgical therapeutic approaches 33
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 33
Effects of germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study 33
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma 33
Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing's Syndrome: Results From a Single Center Cohort Study 32
Current evidence on vitamin D deficiency and kidney transplant: What's new? 32
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 32
Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma 32
Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism 31
Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma 31
Consecutive adrenal Cushing´s syndrome and Cushing´s disease in a patient with somatic CTNNB1, USP8, and NR3C1 mutations 30
Novel AIP mutation in exon 6 causing acromegaly in a German family 30
Morbidity in Patients with Chronic Adrenal Insufficiency - Cardiovascular Risk Factors and Hospitalization Rate Compared to Population Based Controls 30
RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights 30
Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers 30
Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety 29
Targeted gene expression profile reveals CDK4 as therapeutic target for selected patients with adrenocortical carcinoma 29
Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study 29
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 29
The Importance of Being a ‘Lark' in Post-Menopausal Women with Obesity: A Ploy to Prevent Type 2 Diabetes Mellitus? 27
Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning 26
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation 26
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma 26
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma 25
Bone metabolism, bone mass and structural integrity profile in professional male football players 25
Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study 24
Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports 22
Totale 4.392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025875 0 0 0 0 0 0 0 0 275 206 50 344
2025/20263.617 178 439 479 262 486 149 427 90 418 277 209 203
Totale 4.492